| |
| |
|
| Insider
Information: |
Haluska Frank |
| Relationship: |
SVP, Clinical R&D, CMO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
147,011 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
147,011 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Clinical R&D, CMO |
2016-03-21 |
147,011 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$23,116 |
D/D |
(3,575) |
147,011 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
150,586 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2016-03-03 |
4 |
AS |
$6.11 |
$64,733 |
D/D |
(10,588) |
144,086 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
154,674 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
151,557 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$77,587 |
D/D |
(16,133) |
135,424 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$35,503 |
D/D |
(5,500) |
122,224 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
127,724 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$37,575 |
D/D |
(4,400) |
117,724 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
122,124 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$28,229 |
D/D |
(3,300) |
114,124 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
117,424 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$31,634 |
D/D |
(3,575) |
111,424 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
114,999 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$102,107 |
D/D |
(16,134) |
108,499 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
124,633 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
97,907 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$14,527 |
D/D |
(2,608) |
95,299 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-04-02 |
4 |
AS |
$8.21 |
$27,916 |
D/D |
(3,400) |
104,296 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
107,696 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-03-21 |
4 |
AS |
$7.89 |
$18,941 |
D/D |
(2,400) |
99,196 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
101,596 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-03-19 |
4 |
D |
$8.19 |
$16,880 |
D/D |
(2,061) |
95,596 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2014-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
97,657 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Clinical R&D, CMO |
• • – |
2013-12-19 |
4 |
AS |
$5.14 |
$26,214 |
D/D |
(5,100) |
91,157 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
